Related Experiment Video
Updated: Dec 11, 2025

Intravital Microscopy of the Inguinal Lymph Node
Published on: April 4, 2011
Laparoscopically assisted ilio-inguinal lymph node dissection versus inguinal lymph node dissection in melanoma.
Enrique Boldo1, Araceli Mayol1, Rafael Lozoya1
1Department of Surgery Consorcio Hospitalario Provincial de Castellon, Castellón, Spain.
Laparoscopically assisted ilio-inguinal lymphadenectomy (LIIL) significantly reduces complications and hospital stay compared to open inguinal lymphadenectomy (OIL). However, further research is needed to address local recurrence rates and overall survival observed in the LIIL group.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
- Oncology
Background:
- Open inguinal lymphadenectomy (OIL) is associated with high morbidity.
- Minimally invasive techniques are sought to improve patient outcomes in cancer surgery.
Observation:
- A retrospective study compared 14 patients undergoing laparoscopically assisted ilio-inguinal lymphadenectomy (LIIL) with 7 patients who had OIL.
- Pelvic lymph node involvement was often undetected preoperatively.
Findings:
- LIIL demonstrated a statistically significant reduction in morbidity (15.3% vs. 75%) and hospital stay (7 vs. 15.7 days) compared to OIL.
- Despite reduced complications, LIIL showed higher local recurrence rates (58.3% vs. 40%) and lower overall survival than OIL.
- Preoperative detection of pelvic lymph node involvement was limited.
Implications:
- LIIL offers a less morbid alternative to OIL, improving short-term recovery.
- Strategies to mitigate higher local recurrence and improve survival in LIIL are warranted.
- Improved preoperative staging may be necessary for optimal patient selection and outcomes.
More Related Videos
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022